Drug factory · FDA FEI 3010642517
Orion Corporation, Orion Pharma
Joensuunkatu 7, Salo, Finland
Problems found, fixed voluntarily at FDA's last inspection, Oct 25, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2015: 1 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Darolutamide | Packages it and labels it | Bayer HealthCare Pharmaceuticals Inc. | 50419-395 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Oct 25, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 29, 2015 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: label; pack.